Youfu Luo

2.4k total citations
118 papers, 1.8k citations indexed

About

Youfu Luo is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Youfu Luo has authored 118 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 33 papers in Organic Chemistry and 24 papers in Infectious Diseases. Recurrent topics in Youfu Luo's work include Cancer therapeutics and mechanisms (13 papers), Synthesis and biological activity (12 papers) and Biochemical and Molecular Research (12 papers). Youfu Luo is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Synthesis and biological activity (12 papers) and Biochemical and Molecular Research (12 papers). Youfu Luo collaborates with scholars based in China, United States and Switzerland. Youfu Luo's co-authors include Tao Yang, Wenliang Qiao, Zitai Sang, Yuquan Wei, Yong Deng, Wei Ang, Qi An, Chungen Li, Yang Yang and Pingxian Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Molecular Biology and Chemical Communications.

In The Last Decade

Youfu Luo

111 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youfu Luo China 24 888 578 192 155 150 118 1.8k
Yashpal S. Chhonker United States 25 809 0.9× 263 0.5× 189 1.0× 130 0.8× 204 1.4× 108 2.1k
Jerônimo Lameira Brazil 22 768 0.9× 477 0.8× 229 1.2× 125 0.8× 71 0.5× 97 1.7k
Prashant S. Kharkar India 25 705 0.8× 465 0.8× 134 0.7× 143 0.9× 134 0.9× 83 1.6k
Anil Kumar Chhillar India 26 672 0.8× 515 0.9× 149 0.8× 103 0.7× 157 1.0× 103 2.2k
Marina Sala Italy 23 796 0.9× 459 0.8× 84 0.4× 127 0.8× 131 0.9× 66 1.8k
Moataz A. Shaldam Egypt 24 827 0.9× 564 1.0× 125 0.7× 154 1.0× 146 1.0× 75 1.5k
Piyush Trivedi India 26 993 1.1× 1.0k 1.8× 62 0.3× 240 1.5× 221 1.5× 144 2.5k
Pascal Sonnet France 28 1.0k 1.1× 900 1.6× 101 0.5× 124 0.8× 159 1.1× 140 2.5k
Joanna Stefańska Poland 28 878 1.0× 781 1.4× 114 0.6× 254 1.6× 154 1.0× 94 2.3k
Rabi Sankar Bhatta India 24 601 0.7× 357 0.6× 75 0.4× 118 0.8× 339 2.3× 136 2.2k

Countries citing papers authored by Youfu Luo

Since Specialization
Citations

This map shows the geographic impact of Youfu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youfu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youfu Luo more than expected).

Fields of papers citing papers by Youfu Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youfu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youfu Luo. The network helps show where Youfu Luo may publish in the future.

Co-authorship network of co-authors of Youfu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Youfu Luo. A scholar is included among the top collaborators of Youfu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youfu Luo. Youfu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Tao, et al.. (2025). Host-directed therapeutic targets in macrophages and their ligands against mycobacteria tuberculosis. Infection and Immunity. 93(10). e0006325–e0006325.
2.
Qiao, Wenliang, Lijiao Wang, Youfu Luo, & Tao Yang. (2025). Synthetic approaches and therapeutic applications of FDA-approved antibacterial agents: A comprehensive review from 2003 to 2023. European Journal of Medicinal Chemistry. 285. 117267–117267. 4 indexed citations
3.
4.
Jiang, Yunhan, Xiaoqiu Xu, Dongmei Fan, et al.. (2024). Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate. Journal of Medicinal Chemistry. 67(16). 13959–13974. 11 indexed citations
5.
Xian, Peng, et al.. (2023). Small molecule II-6s synergises with fluconazole against Candida albicans. International Journal of Antimicrobial Agents. 62(1). 106820–106820. 5 indexed citations
6.
Zhou, Yang, Jiao Zou, Xi Zhong, et al.. (2023). Synthesis and biological evaluation of novel pyrazole amides as potent mitochondrial complex I inhibitors. European Journal of Medicinal Chemistry. 258. 115576–115576. 2 indexed citations
7.
Luo, Bingnan, Yingjie Song, Yonghong Zhou, et al.. (2023). Pseudomonas aeruginosa regulator PvrA binds simultaneously to multiple pseudo-palindromic sites for efficient transcription activation. Science China Life Sciences. 67(5). 900–912.
8.
Jiang, Yunhan, et al.. (2023). Facilitating the development of molecular glues: Opportunities from serendipity and rational design. European Journal of Medicinal Chemistry. 263. 115950–115950. 12 indexed citations
9.
An, Qi, Xiaofei Shen, Chungen Li, et al.. (2021). Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1. Journal of Medicinal Chemistry. 64(10). 6596–6607. 20 indexed citations
10.
Yang, Ran, et al.. (2021). Antimicrobial activities of a small molecule compound II-6s against oral streptococci. Journal of Oral Microbiology. 13(1). 1909917–1909917. 13 indexed citations
11.
Peng, Xian, Qian Xie, Jiyao Li, et al.. (2021). A small molecule II-6s inhibits Enterococcus faecalis biofilms. Journal of Oral Microbiology. 13(1). 1978756–1978756. 5 indexed citations
12.
Tan, Yuping, Xia Zhou, Yanqiu Gong, et al.. (2021). Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors. Cellular and Molecular Life Sciences. 79(1). 27–27. 12 indexed citations
13.
Ma, Yu, et al.. (2021). Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction. Drug Discovery Today. 26(4). 968–981. 35 indexed citations
14.
Ren, Wen, Qian Zhao, Meng Yu, et al.. (2019). Design and synthesis of novel spirooxindole–indenoquinoxaline derivatives as novel tryptophanyl-tRNA synthetase inhibitors. Molecular Diversity. 24(4). 1043–1063. 22 indexed citations
15.
Chen, Yao, Yuan Ju, Chungen Li, et al.. (2019). Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection. The Journal of Antibiotics. 72(7). 545–554. 7 indexed citations
16.
Ang, Wei, Weiwei Ye, Zitai Sang, et al.. (2014). Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 24(6). 1496–1501. 19 indexed citations
17.
Wang, Zhenling, Jianzhong Yang, Tao Yang, et al.. (2011). Design, synthesis and evaluation of novel molecules with a diphenyl ether nucleus as potential antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 22(2). 954–957. 20 indexed citations
18.
Bachir, Alexia I., et al.. (2005). Lateral diffusion of CFTR on the cell surface measured using an engineered biotinylation target sequence. Proceedings of The Physiological Society. 31(10). e433–e435. 1 indexed citations
19.
Chen, Fen‐Er, et al.. (2002). Studies on the Asymmetric Total Synthesis of d-Biotin(V). Gaodeng xuexiao huaxue xuebao. 23(6). 1060. 1 indexed citations
20.
Luo, Youfu & Wei Xiong. (1991). [Chemical constituents of anticancer plant Nyssa sinensis Oliv].. PubMed. 16(7). 424–5, 448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yashpal S. Chhonker Breakdown of academic impact, for papers by Jerônimo Lameira Breakdown of academic impact, for papers by Prashant S. Kharkar Breakdown of academic impact, for papers by Anil Kumar Chhillar Breakdown of academic impact, for papers by Marina Sala Breakdown of academic impact, for papers by Moataz A. Shaldam Breakdown of academic impact, for papers by Piyush Trivedi Breakdown of academic impact, for papers by Pascal Sonnet Breakdown of academic impact, for papers by Joanna Stefańska Breakdown of academic impact, for papers by Rabi Sankar Bhatta
Rankless by CCL
2026